Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (June 2025)
07:05am, Thursday, 12'th Jun 2025
From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%.
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
02:00pm, Wednesday, 11'th Jun 2025
Novo Nordisk's drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC's Disruptor 50 List.
Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space?
10:40am, Wednesday, 11'th Jun 2025
LLY banks on soaring Mounjaro and Zepbound sales to defend its obesity edge amid intensifying competition.
Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health
07:30am, Wednesday, 11'th Jun 2025
Research will leverage world's first AI-enabled screening platform for mapping the therapeutic potential of secreted signaling proteins, developed by Juvena Collaboration aims to accelerate the discov
Should You Buy Eli Lilly Stock Before June 22?
04:23am, Wednesday, 11'th Jun 2025
Eli Lilly (LLY 4.33%) stock hasn't been doing too well this year, but that could change later this month. A couple of key events are on the horizon this month during which the company will release new
Drug pricing reform talks with US government lack clarity, industry executives say
02:03pm, Tuesday, 10'th Jun 2025
Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how reduced prices will be implemented, top executives from Eli Lilly and Merck said at
Eli Lilly and Company (LLY) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript
10:14am, Tuesday, 10'th Jun 2025
Eli Lilly and Company (NYSE:LLY ) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 8:00 AM ET Company Participants Lucas E. Montarce - Executive VP & CFO Michael Czapar - Director
The Highest-Quality Dividend Contenders By Quality Scores
09:00am, Tuesday, 10'th Jun 2025
The article presents the highest-quality Dividend Contenders, companies listed on U.S. exchanges with higher annual dividend payouts for 10-24 consecutive years. I use a quality scoring system with si
2 Weight Loss Drug Stocks That Are Screaming Buys in June
03:33am, Tuesday, 10'th Jun 2025
Is there a hotter trend in healthcare than weight loss drugs? Probably not.
Visa, Eli Lilly or Netflix— Which Stock Will Be A Trillion Dollar Company Next?
01:36pm, Monday, 09'th Jun 2025
Justin Sullivan / Getty Images Visa Fintech is changing the world and Visa is at the center of it.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Monday, 09'th Jun 2025
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
5 Monster Stocks to Hold for the Next 10 Years
04:25am, Monday, 09'th Jun 2025
With the stock market settling in after a volatile period, now is a good time to start looking at some leading growth stocks that have strong potential over the next decade.
You don't have to be a billionaire to invest like one -- and reap the rewards. Any of us can look at the moves made by the world's most successful investors and follow those that also fit into our inv
Rare Outflow Signals Hit Eli Lilly Shares
06:38am, Friday, 06'th Jun 2025
“Buy low, sell high” is a common investing mantra. It's easy to understand, but often hard to execute because emotion gets in the way.
Lilly's Jake Van Naarden: Lilly's success with GLP-1's allows us to reinvest in oncology
09:39am, Thursday, 05'th Jun 2025
CNBC's Angelica Peebles sits down with Lilly's Head of Oncology, Jake Van Naarden, to discuss what's next in Lilly's oncology pipeline and what Lilly is changing about its clinical trials to make them
